In the summer of 2025, David Medical made its debut at the European Society for Pediatric and Neonatal Intensive Care (ESPNIC) with an all-new technological matrix. Under the theme "Smart Healthcare, Guardian of Life," the company showcased a range of high-end products and solutions, standing out as a highlight of the event. Together with industry elites from around the world, David Medical explored new frontiers in global medical technology.
From June 25 to 28, the 34th ESPNIC Conference was grandly held in Alicante, Spain, at the Adda Convention Center. As one of Europe's oldest and largest pediatric societies, ESPNIC is a professional organization dedicated to pediatric and neonatal intensive care, focusing on critically ill children with complex conditions who rely on life-support technologies and multidisciplinary emergency management.
At this premier international academic event, David Medical presented its core products, including the TI-3000B Transport Incubator, HKN-2200B Infant Radiant Warmer, YP-3100B Infant Incubator, and BM-100A Transcutaneous Jaundice Detector. With their outstanding technical performance and innovative design, these products attracted significant attention and engagement from international medical professionals.
TI-3000B Transport Incubator: Provides constant-temperature, stable support for critically ill newborns/premature infants during intra- and inter-hospital transport.
YP-3100B Infant Incubator: Offers a warm, clean growth environment for premature and sick newborns.
HKN-2200B Infant Radiant Warmer: Delivers a comfortable thermal environment, ideal for neonatal resuscitation, examinations, and medical procedures.
BM-100A Transcutaneous Jaundice Detector: Enables convenient, non-invasive monitoring of neonatal bilirubin levels.
During the exhibition, David Medical's technological strengths received high recognition from European and global professionals. Through in-depth exchanges with European medical experts, scholars, and practitioners, the company gained deeper insights into the specific needs and technological trends of the European pediatric intensive care market.
This successful participation in ESPNIC 2025 not only demonstrated David Medical's innovation capabilities in high-end neonatal care equipment and the prowess of "Intelligent Manufacturing from China" but also laid a solid foundation for the company's future strategic expansion, business growth, and enhanced international collaboration in the European market.
Moving forward, David Medical will remain committed to research and innovation in pediatric and neonatal intensive care technologies, delivering more efficient and intelligent medical solutions to safeguard the health of children worldwide and drive industry progress.
